For the Inventor, By the Inventor

Enter assignee name

Beaverton, OR, United States of America

Viscardia, Inc.

USPTO Granted Patents = 21

EPO Patents = 5

Trademarks = 3

Forward Citations = 164

Loading Chart...

Loading Chart...

6 inventors (with patents filed for the assignee):

Peter T Bauer (21 out of 35 patents)

Edward Chinchoy (8 out of 8 patents)

Jay Snell (8 out of 15 patents)

4. Timothy K Wheeler (5 out of 8 patents)

5. Patricia A Arand (2 out of 23 patents)

6. Gregg Harris (1 out of 1 patent)

21 patents: Sort by Forward Citations

1. 12364859 - Systems, devices, and methods for improving hemodynamic performance through asymptomatic diaphragm stimulation (2025-07-22),

2. 12357825 - Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health (2025-07-15),

3. 12144993 - Hemodynamic performance enhancement through asymptomatic diaphragm stimulation (2024-11-19),

4. 11957914 - Implantable medical systems, devices and methods for delivering asymptomatic diaphragmatic stimulation (2024-04-16),

5. 11925803 - Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health (2024-03-12),

6. 11911616 - Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health (2024-02-27),

7. 11684783 - Hemodynamic performance enhancement through asymptomatic diaphragm stimulation (2023-06-27),

8. 11666757 - Systems, devices, and methods for improving hemodynamic performance through asymptomatic diaphragm stimulation (2023-06-06),

9. 11524158 - Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health (2022-12-13),

10. 11458312 - Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health (2022-10-04),

11. 11400286 - Implantable medical devices, systems, and methods for selection of optimal diaphragmatic stimulation parameters to affect pressures within the intrathoracic cavity (2022-08-02),

12. 11147968 - Systems, devices, and methods for improving hemodynamic performance through asymptomatic diaphragm stimulation (2021-10-19),

13. 11020596 - Hemodynamic performance enhancement through asymptomatic diaphragm stimulation (2021-06-01),

14. 10537735 - Implantable medical devices and methods for real-time or near real-time adjustment of diaphragmatic stimulation parameters to affect pressures within the intrathoracic cavity (2020-01-21),

15. 10493271 - Implantable medical devices, systems, and methods for selection of optimal diaphragmatic stimulation parameters to affect pressures within the intrathoracic cavity (2019-12-03),

VisCardia, Inc. is a medical technology company focused on developing innovative therapies for cardiovascular conditions. With a vision to improve patients' lives, VisCardia aims to address unmet needs in cardiovascular care through its groundbreaking solutions. The company's website provides detailed information about their cutting-edge technologies, ongoing research, and commitment to revolutionize cardiovascular medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Viscardia, Inc.

21 Patents

#21 in Beaverton, OR

#163 in Oregon

#15,651 in US

#29,850 in the World

Beaverton, OR, United States of America

Viscardia, Inc.

Forward Citations = 164

6 inventors:

Peter T Bauer (21 out of 35 patents)

Edward Chinchoy (8 out of 8 patents)

Jay Snell (8 out of 15 patents)

4. Timothy K Wheeler (5 out of 8 patents)

5. Patricia A Arand (2 out of 23 patents)

Please report any incorrect information to [email protected]

Loading…